TY  - GEN
AU  - Bousser,M G
AU  - Amarenco,P
AU  - Chamorro,A
AU  - Fisher,M
AU  - Ford,I
AU  - Fox,K
AU  - Hennerici,M G
AU  - Mattle,H P
AU  - Rothwell,P M
TI  - Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and cardiovascular events of ischemic origin with terutroban in patients with a history of ischemic stroke or transient ischemic attack (PERFORM) study
SN  - 1421-9786
PY  - 2009///0722
KW  - Aged
KW  - Aged, 80 and over
KW  - Aspirin
KW  - adverse effects
KW  - Cardiovascular Diseases
KW  - etiology
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Endpoint Determination
KW  - Female
KW  - Humans
KW  - International Cooperation
KW  - Ischemic Attack, Transient
KW  - complications
KW  - Male
KW  - Middle Aged
KW  - Naphthalenes
KW  - Platelet Aggregation Inhibitors
KW  - Propionates
KW  - Receptors, Thromboxane
KW  - antagonists & inhibitors
KW  - Stroke
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1159/000212671
ER  -